The authors evaluated the feasibility, clinical yield, and localization precision of high-resolution EEG source imaging of interictal epileptic activity. A consecutive series of 44 patients with intractable epilepsy of various causes, who underwent a comprehensive presurgical epilepsy evaluation, were subjected to a 128-channel EEG recording. A standardized source imaging procedure constrained to the individual gray matter was applied to the averaged spikes of each patient. In 32 patients, the presurgical workup identified a focal epileptogenic area. The 128-channel EEG source imaging correctly localized this area in 30 of these patients (93.7%). Imprecise localization was explained by simplifications of the recordings and analysis procedure, which was accepted for the benefit of speed and standardization. In a subgroup of 24 patients who underwent operations, the sublobar precision of the 128-channel EEG source imaging was evaluated by calculating the distance of the source maximum to the resected area. This analysis revealed zero distance in 19 cases (79%). The authors conclude that high-resolution interictal EEG source imaging is a valuable noninvasive functional neuroimaging technique. The speed, ease, flexibility, and low cost of this technique warrant its use in clinical practice.
The relationship between interictal epileptiform activity and the epileptogenic zone is complex. Despite the fact that intraspike propagation may occur, the peak of the spike is often used as indicator of the site of ictal onset. In this investigation, spatio-temporal segmentation was used to demonstrate this intraspike propagation and to determine at which time point the voltage pattern corresponded best to the epileptogenic zone. Sixteen patients with focal epilepsy were recorded with 125-channel EEG. Between one and five different map topographies were identified during the rising phase of the spike. A distributed source model (EPIFOCUS) was used to localize the source of each map, and the distance from the EPIFOCUS maximum to the anatomic lesion was calculated. In only 3 of 16 cases was the entire rising phase of the spike accounted for by one single map. In another five patients, several maps were obtained, although all were located within the epileptogenic lesion. In the remaining eight patients, however, parts of the rising phase had locations outside the epileptogenic lesion. On the average, 80% of the rising time had within lesion locations the most reliable time period being halfway between onset and peak. The results illustrate that intraspike propagation has to be considered in source localizations, and they also illustrate the usefulness of spatio-temporal segmentation for visualizing this propagation.
Summary:Purpose: Epilepsy is a relatively frequent disease in children, with considerable impact on cognitive and social life. Successful epilepsy surgery depends on unambiguous focus identification and requires a comprehensive presurgical workup, including several neuroimaging techniques [magnetic resonance imaging, positron emission tomography (PET), and single-photon emission computed tomography (SPECT)]. These may be difficult to apply in younger or developmentally delayed children or both, requiring sedation, and hence, a significant workforce. Modern electric source imaging (ESI) provides accurate epileptic source-localization information in most patients, with minimal patient discomfort or need for cooperation. The purpose of the present study was to determine the usefulness of ESI in pediatric EEG recordings performed with routine electrode arrays.Methods: Preoperative EEGs recorded from 19 to 29 scalp electrodes were reviewed, and interictal epileptiform activity was analyzed by using a linear source-imaging procedure (depthweighted minimum norm) in combination with statistical parametric mapping.Results: In 27 (90%) of 30 patients, the ESI correctly localized the epileptogenic region. These numbers compare favorably with the results from other imaging techniques in the same patients (PET, 82%; ictal SPECT, 70%). In extratemporal epilepsy, ESI was correct in all cases, and in temporal lobe epilepsy, in 10 of 13 cases. In two temporal lobe patients showing less-accurate ESI results, 128-electrode data could be analyzed, and in both cases, the 128-electrode ESI was correct.Conclusions: ESI with standard clinical EEG recordings provides excellent localizing information in pediatric patients, in particular in extratemporal lobe epilepsy. The lower yield in temporal lobe epilepsy seems to be due to undersampling of basal temporal areas with routine scalp recordings. Key Words: Epilepsy-Pediatric-EEG-Source imaging.The indication for early surgical intervention in children with refractory epilepsy should be actively investigated for two reasons: (a) to avoid the deleterious effect of epileptic seizures and antiepileptic medication on cognitive, intellectual, and social development (1,2); and (b) to increase the chances of postoperative functional reorganization due to the expected higher degree of brain plasticity in children (3-5). The surgical outcome is similar to that in adults (6-8) (i.e., between 60 and 80% of patients with temporal lobe epilepsy are postoperatively seizure free) (8-10). However, in extratemporal epilepsy, which is more frequent in pediatric patients, the outcome is still somewhat less favorable compared with surgical treatment of temporal lobe seizures. Overall, 50-75% benefit from surgical treatment, and evidence converges that the outcome deAccepted January 15, 2006. Address correspondence and reprint requests to Dr. G. Lantz at Functional Brain Mapping Laboratory, Department of Neurology, University Hospital, 24 Rue Micheli-du-Crest, CH-1211 Genève 14, Switzerland. E-mail Goran.Lant...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.